However, there was a statistically significant negative correlation between TGF-β levels before the intervention and TCNSs after the intervention (r = −0.326; p = 0.045), suggesting that higher baseline TGF-β levels were associated with lower neuropathy symptoms after the intervention. The gene discussed is TGFB1; the disease is neuropathy.